PR Newswire Feeds

Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73 Inhibitor) for the Treatment of Locally Advanced or Metastatic Solid Tumors in China. Dr Amit Kakar joins MedGenome Board of Directors BANGALORE, India, Wed, Nov 2 2022 10:00 AM The company has also added Navjeewan Khosla from Novo Holdings as Board Observer. | PR Newswire

Health Care Asia

Home

PR Newswire Feeds